Sang-Beom Jeon1, H Alex Choi2, Neeraj Badjatia3, J Michael Schmidt4, Hector Lantigua4, Jan Claassen4, E Sander Connolly5, Stephan A Mayer4, Kiwon Lee2. 1. Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea Departments of Neurology and Neurosurgery, The University of Texas Medical School at Houston, Houston, Texas, USA Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York, USA. 2. Departments of Neurology and Neurosurgery, The University of Texas Medical School at Houston, Houston, Texas, USA Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York, USA. 3. Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York, USA Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, USA. 4. Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York, USA. 5. Departments of Neurosurgery, Columbia University College of Physicians and Surgeons, New York, New York, USA.
Abstract
OBJECTIVE: To determine the association between exposure to hyperoxia and the risk of delayed cerebral ischaemia (DCI) after subarachnoid haemorrhage (SAH). METHODS: We analysed data from a single centre, prospective, observational cohort database. Patient inclusion criteria were age ≥18 years, aneurysmal SAH, endotracheal intubation with mechanical ventilation, and arterial partial pressure of oxygen (PaO2) measurements. Hyperoxia was defined as the highest quartile of an area under the curve of PaO2, until the development of DCI (PaO2≥173 mm Hg). Poor outcome was defined as modified Rankin Scale 4-6 at 3 months after SAH. RESULTS: Of 252 patients, there were no differences in baseline characteristics between the hyperoxia and control group. Ninety-seven (38.5%) patients developed DCI. The hyperoxia group had a higher incidence of DCI (p<0.001) and poor outcome (p=0.087). After adjusting for modified Fisher scale, rebleeding, global cerebral oedema, intracranial pressure crisis, pneumonia and sepsis, hyperoxia was independently associated with DCI (OR, 3.16; 95% CI 1.69 to 5.92; p<0.001). After adjusting for age, Hunt-Hess grade, aneurysm size, Acute Physiology and Chronic Health Evaluation II score, rebleeding, pneumonia and sepsis, hyperoxia was independently associated with poor outcome (OR, 2.30; 95% CI 1.03 to 5.12; p=0.042). CONCLUSIONS: In SAH patients, exposure to hyperoxia was associated with DCI. Our findings suggest that exposure to excess oxygen after SAH may represent a modifiable factor for morbidity and mortality in this population. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: To determine the association between exposure to hyperoxia and the risk of delayed cerebral ischaemia (DCI) after subarachnoid haemorrhage (SAH). METHODS: We analysed data from a single centre, prospective, observational cohort database. Patient inclusion criteria were age ≥18 years, aneurysmalSAH, endotracheal intubation with mechanical ventilation, and arterial partial pressure of oxygen (PaO2) measurements. Hyperoxia was defined as the highest quartile of an area under the curve of PaO2, until the development of DCI (PaO2≥173 mm Hg). Poor outcome was defined as modified Rankin Scale 4-6 at 3 months after SAH. RESULTS: Of 252 patients, there were no differences in baseline characteristics between the hyperoxia and control group. Ninety-seven (38.5%) patients developed DCI. The hyperoxia group had a higher incidence of DCI (p<0.001) and poor outcome (p=0.087). After adjusting for modified Fisher scale, rebleeding, global cerebral oedema, intracranial pressure crisis, pneumonia and sepsis, hyperoxia was independently associated with DCI (OR, 3.16; 95% CI 1.69 to 5.92; p<0.001). After adjusting for age, Hunt-Hess grade, aneurysm size, Acute Physiology and Chronic Health Evaluation II score, rebleeding, pneumonia and sepsis, hyperoxia was independently associated with poor outcome (OR, 2.30; 95% CI 1.03 to 5.12; p=0.042). CONCLUSIONS: In SAHpatients, exposure to hyperoxia was associated with DCI. Our findings suggest that exposure to excess oxygen after SAH may represent a modifiable factor for morbidity and mortality in this population. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Sahar F Zafar; Eva N Postma; Siddharth Biswal; Lucas Fleuren; Emily J Boyle; Sophia Bechek; Kathryn O'Connor; Apeksha Shenoy; Durga Jonnalagadda; Jennifer Kim; Mouhsin S Shafi; Aman B Patel; Eric S Rosenthal; M Brandon Westover Journal: Neurocrit Care Date: 2018-04 Impact factor: 3.210
Authors: Teodor Svedung Wettervik; Henrik Engquist; Anders Hånell; Timothy Howells; Elham Rostami; Elisabeth Ronne-Engström; Anders Lewén; Per Enblad Journal: Neurocrit Care Date: 2022-04-21 Impact factor: 3.532
Authors: Hendrik J F Helmerhorst; Marcus J Schultz; Peter H J van der Voort; Evert de Jonge; David J van Westerloo Journal: Crit Care Date: 2015-08-17 Impact factor: 9.097
Authors: Sebastian Hafner; François Beloncle; Andreas Koch; Peter Radermacher; Pierre Asfar Journal: Ann Intensive Care Date: 2015-11-19 Impact factor: 6.925
Authors: Sean N Neifert; Emily K Chapman; Michael L Martini; William H Shuman; Alexander J Schupper; Eric K Oermann; J Mocco; R Loch Macdonald Journal: Transl Stroke Res Date: 2020-10-19 Impact factor: 6.829
Authors: Julien Demiselle; Enrico Calzia; Clair Hartmann; David Alexander Christian Messerer; Pierre Asfar; Peter Radermacher; Thomas Datzmann Journal: Ann Intensive Care Date: 2021-06-02 Impact factor: 6.925